Healthpeak Properties (NYSE:DOC) Releases FY24 Earnings Guidance

Healthpeak Properties (NYSE:DOC) updated its FY24 earnings guidance on Monday. The company provided earnings per share (EPS) guidance of $1.80-$1.82 for the period, compared to the consensus estimate of $1.80.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock traded up $0.01 during trading on Monday, reaching $20.87. The company’s stock had a trading volume of 5,160,296 shares, compared to its average volume of 5,742,458. The business’s 50-day moving average price is $22.26 and its 200-day moving average price is $21.08. The company has a quick ratio of 1.31, a current ratio of 1.31 and a debt-to-equity ratio of 0.93. Healthpeak Properties has a 52 week low of $16.01 and a 52 week high of $23.26. The firm has a market cap of $14.60 billion, a PE ratio of 44.38, a P/E/G ratio of 2.32 and a beta of 1.13.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings results on Thursday, October 24th. The real estate investment trust reported $0.12 earnings per share for the quarter, missing analysts’ consensus estimates of $0.44 by ($0.32). The business had revenue of $700.40 million for the quarter, compared to analyst estimates of $682.51 million. Healthpeak Properties had a return on equity of 3.53% and a net margin of 12.10%. The business’s revenue was up 25.9% on a year-over-year basis. During the same quarter in the previous year, the business posted $0.45 earnings per share. Equities analysts forecast that Healthpeak Properties will post 1.8 earnings per share for the current year.

Healthpeak Properties Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Friday, November 15th. Investors of record on Monday, November 4th were paid a dividend of $0.30 per share. This represents a $1.20 dividend on an annualized basis and a yield of 5.75%. The ex-dividend date of this dividend was Monday, November 4th. Healthpeak Properties’s dividend payout ratio (DPR) is currently 255.32%.

Wall Street Analysts Forecast Growth

Several research firms recently weighed in on DOC. Citigroup upped their price objective on shares of Healthpeak Properties from $20.00 to $22.00 and gave the stock a “neutral” rating in a research report on Thursday, August 22nd. Evercore ISI lifted their price target on shares of Healthpeak Properties from $25.00 to $26.00 and gave the stock an “outperform” rating in a research note on Monday, September 16th. Wedbush lifted their target price on shares of Healthpeak Properties from $22.00 to $25.00 and gave the stock an “outperform” rating in a research report on Monday, July 29th. Scotiabank boosted their target price on Healthpeak Properties from $23.00 to $24.00 and gave the company a “sector outperform” rating in a research note on Monday, September 9th. Finally, Wells Fargo & Company reaffirmed an “equal weight” rating and set a $23.00 target price (up previously from $22.00) on shares of Healthpeak Properties in a research note on Tuesday, October 1st. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company. According to MarketBeat, the company presently has a consensus rating of “Moderate Buy” and an average price target of $22.86.

About Healthpeak Properties

Healthpeak Properties, Inc is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.